AGT

Angiotensinogen (AGT), a vital enzyme in the renin-angiotensin system (RAS) regulating blood pressure and cardiovascular functions, is influenced by genetic variations associated with hypertension.  

Variants in the AGT gene have been linked to hypertension development, with specific single nucleotide polymorphisms (SNPs) like rs5050 affecting cardiovascular disease susceptibility, potentially through elevated plasma AGT concentrations leading to vascular injury. 

This insight into AGT genetics offers avenues for personalized risk assessment and treatment strategies in cardiovascular care, emphasizing the importance of individualized medicine approaches tailored to genetic profiles.

Understanding Angiotensinogen (AGT): What is AGT?  

The Angiotensinogen (AGT) enzyme, a pivotal component of the RAAS system regulating blood pressure and cardiovascular functions, is subject to genetic variations associated with hypertension.  

This enzyme is coded by the AGT gene, and many alterations in this gene have been linked with the development of hypertension.  

Definition and Biological Role of AGT  [3.] 

AGT is a glycoprotein primarily produced by the liver and secreted into the bloodstream.  It serves as the substrate for renin, which cleaves AGT to form angiotensin I. 

This peptide is subsequently converted into angiotensin II by the angiotensin-converting enzyme (ACE), a potent vasoconstrictor that plays a crucial role in regulating blood pressure and fluid balance.  Angiotensin II also stimulates the release of aldosterone from the adrenal glands, which promotes sodium and water retention in the kidneys, further influencing blood pressure levels.

AGT is also associated with pregnancy-induced hypertension and preeclampsia.  [3.] 

How AGT Functions in the Renin-Angiotensin System  [1.]

The RAS is integral to cardiovascular physiology, affecting various functions such as blood vessel tone, kidney function, and sodium retention. As the initial component of this system, AGT's availability and activity are critical for the proper functioning of the RAS. 

The regulation of AGT production in the liver is influenced by several factors including hormonal signals, blood pressure, blood volume, and the body's sodium levels.

AGT's Role in Regulating Blood Pressure and Electrolyte Balance  [1.]

In addition to its vasoconstrictive actions, AGT through its product angiotensin II significantly impacts renal function and electrolyte balance. 

Angiotensin II not only prompts the kidneys to reabsorb sodium, leading to increased blood volume and pressure, but also affects potassium excretion and acid-base balance. 

The AGT Gene and Hypertension

Studies have confirmed the significance of AGT gene variants in hypertension by highlighting the genetic underpinnings of hypertension, particularly in the context of AGT variability.   

One study identified four significant SNPs and three haplotypes within the AGT promoter and gene region strongly associated with hypertension, along with one haplotype showing a protective effect.  [5.]

Research on AGT gene variants in hypertension studies elucidate the complex interplay between genetic predisposition and environmental factors in hypertension etiology. 

Specific SNPs identified in the AGT gene that can affect blood pressure include: 

rs5050  [4.]

The rs5050 SNP, located in the promoter region of the angiotensinogen (AGT) gene, is associated with an increased risk of coronary artery aneurysm (CAA) in children with Kawasaki disease (KD), particularly those younger than 12 months. 

This SNP influences the transcription rate of the AGT gene, potentially leading to elevated plasma AGT concentrations and subsequent vascular injury, contributing to cardiovascular disease susceptibility.  

g.5855G>A  [2.]

Significant association was observed between the g.5855G>A polymorphism and essential hypertension, with the G allele showing a protective effect against the condition. 

This polymorphism influenced mRNA splicing by creating a new exonic splicing enhancer and disrupting an exonic splicing silencer site.  Haplotypes AGTG and GACG were also found to have a significant protective effect, while other polymorphisms showed no association with hypertension.

What is a SNP?

A SNP, or single nucleotide polymorphism, refers to a variation at a single position in a gene along its DNA sequence.  A gene encodes a protein, so an alteration in that gene programs the production of an altered protein.  As a type of protein with great functionality in human health, alterations in genes for enzymes may confer a difference in function of that enzyme.  The function of that enzyme may be increased or decreased, depending on the altered protein produced.  

SNPs are the most common type of genetic variation in humans and can occur throughout the genome, influencing traits, susceptibility to diseases, and response to medications.

The completion of the Human Genome Project has significantly expanded opportunities for genetic testing by providing a comprehensive map of the human genome that facilitates the identification of genetic variations associated with various health conditions, including identifying SNPs that may cause alterations in protein structure and function.  

Genetic testing for SNPs enables the identification of alterations in genes, shedding light on their implications in health and disease susceptibility.

Laboratory Testing for AGT

Genetic testing for single nucleotide polymorphisms (SNPs) typically involves obtaining a sample of DNA which can be extracted from blood, saliva, or cheek swabs. 

The sample may be taken in a lab, in the case of a blood sample.  Alternatively, a saliva or cheek swab sample may be taken from the comfort of home. 

Test Preparation

Prior to undergoing genetic testing, it's important to consult with a healthcare provider or genetic counselor to understand the purpose, potential outcomes, and implications of the test.  This consultation may involve discussing medical history, family history, and any specific concerns or questions. 

Additionally, individuals may be advised to refrain from eating, drinking, or chewing gum for a short period before providing a sample to ensure the accuracy of the test results.  Following sample collection, the DNA is processed in a laboratory where it undergoes analysis to identify specific genetic variations or SNPs. 

Once the testing is complete, individuals will typically receive their results along with interpretation and recommendations from a healthcare professional. 

It's crucial to approach genetic testing with proper understanding and consideration of its implications for one's health and well-being.

Patient-Centric Approaches

A patient-centered approach to SNP genetic testing emphasizes individualized medicine, tailoring healthcare decisions and interventions based on an individual's unique genetic makeup.

When that is combined with the individual’s health status and health history, preferences, and values, a truly individualized plan for care is possible. 

By integrating SNP testing into clinical practice, healthcare providers can offer personalized risk assessment, disease prevention strategies, and treatment plans that optimize patient outcomes and well-being. 

Genetic testing empowers a deeper understanding of genetic factors contributing to disease susceptibility, drug response variability, and overall health, empowering patients to actively participate in their care decisions. 

Furthermore, individualized medicine recognizes the importance of considering socioeconomic, cultural, and environmental factors alongside genetic information to deliver holistic and culturally sensitive care that aligns with patients' goals and preferences. 

Through collaborative decision-making and shared decision-making processes, patients and providers can make informed choices about SNP testing, treatment options, and lifestyle modifications, promoting patient autonomy, engagement, and satisfaction in their healthcare journey.

Genetic Panels and Combinations

Integrating multiple biomarkers into panels or combinations enhances the predictive power and clinical utility of pharmacogenomic testing. Biomarker panels comprising a variety of transporter proteins and enzymes including drug metabolizing enzymes offer comprehensive insights into individual drug response variability and treatment outcomes. 

Combining genetic SNP testing associated with drug transport, metabolism, and pharmacodynamics enables personalized medicine approaches tailored to individual patient characteristics and genetic profiles.

Biomarkers and Genes Related to AGT

Renin: Role in RAS and Testing Methods

Renin is a critical enzyme in the renin-angiotensin system that directly interacts with AGT to produce angiotensin I.  It is often measured to evaluate the activity of the RAS, especially in cases of hypertension and renal artery stenosis. 

These tests help determine whether hypertension is due to excessive RAS activity and can guide the choice of antihypertensive therapy, particularly in determining the appropriateness of renin-angiotensin system blockers.

Aldosterone: Its Relationship with AGT and How It Is Tested

Aldosterone, produced by the adrenal glands, plays a crucial role in sodium retention, potassium excretion, and water retention, influencing blood pressure and electrolyte balance.  Its production is stimulated by angiotensin II, derived from AGT. 

Testing for aldosterone is particularly relevant in patients with suspected primary aldosteronism, a common cause of secondary hypertension. 

Laboratory testing typically involves measuring serum aldosterone levels, often coupled with renin levels to calculate the aldosterone-renin ratio (ARR), which helps in diagnosing aldosteronism and distinguishing it from other forms of hypertension.

C-Reactive Protein (CRP): As an Inflammatory Marker Alongside AGT in Cardiovascular Conditions

C-Reactive Protein (CRP) is a well-established inflammatory biomarker often elevated in inflammatory diseases, including those affecting the cardiovascular system. 

Elevated CRP levels can indicate an increased risk of cardiovascular events, and when measured alongside AGT, provide a more comprehensive view of a patient's cardiovascular risk profile.  

High-sensitivity CRP (hs-CRP) tests are commonly used in clinical settings to assess low levels of inflammation that may not be detectable with standard CRP tests, aiding in the risk assessment and management of cardiovascular disease.

BNP (B-type Natriuretic Peptide): Testing and Correlation with AGT in Heart Failure

B-type Natriuretic Peptide (BNP) and its inactive fragment, NT-proBNP, are markers of cardiac strain and are predominantly used in the diagnosis and management of heart failure.  BNP levels rise in response to increased pressure within the heart, typically seen in heart failure conditions. 

Testing for BNP helps in diagnosing heart failure and can be useful in monitoring treatment efficacy.  When analyzed in conjunction with AGT levels, BNP can provide insights into the interplay between heart function and the renin-angiotensin system, enhancing the understanding of cardiovascular pathology and therapeutic approaches.

Order Genetic Testing

Click here to compare genetic test panels and order genetic testing for health-related SNPs.